Josep Maria Piulats is the group leader of the Clinical Research in Solid Tumours group of Oncobell, within Idibell. His group is striving to become the gateway to purely translational/clinical research generated at the ICO and the academic pathway to introducing new treatments. The team’s aim is to transform ideas and hypotheses generated in the cancer-treatment environment into personalised therapies, clinical trials and translation projects. This leads to an increase in the social and bibliometric impact of the research generated by the Oncobell programme and creates synergies between basic and clinical researchers within the programme.